Cargando…
NAD(+) Precursors: A Questionable Redundancy
The last decade has seen a strong proliferation of therapeutic strategies for the treatment of metabolic and age-related diseases based on increasing cellular NAD(+) bioavailability. Among them, the dietary supplementation with NAD(+) precursors—classically known as vitamin B3—has received most of t...
Autor principal: | Canto, Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316858/ https://www.ncbi.nlm.nih.gov/pubmed/35888754 http://dx.doi.org/10.3390/metabo12070630 |
Ejemplares similares
-
Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022) -
A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor
por: Giroud-Gerbetant, Judith, et al.
Publicado: (2019) -
The role of NAD and NAD precursors on longevity and lifespan modulation in the budding yeast, Saccharomyces cerevisiae
por: Odoh, Chuks Kenneth, et al.
Publicado: (2022) -
NAD(+) Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
por: Obrador, Elena, et al.
Publicado: (2021) -
NAD+ Precursors: A Physiological Reboot?
por: Niño-Narvión, Julia, et al.
Publicado: (2023)